Company
Inversago Pharma Inc.
Record updated 21 September 2026
About
Inversago Pharma Inc. is focused on the development of peripherally-restricted CB1 receptor (CB1) inverse agonists for the treatment of Prader-Willi syndrome, type 1 diabetes and metabolic disorders in general.